After months of rumors and speculation, Apple on Friday announced it will offer live races from Formula 1 on an exclusive basis for fans in the United States. The deal is worth around $160 million per ...
The new model offers direct manufacturer pricing for weight loss drugs and a way to contribute to employee costs. WeightWatchers has launched a first-of-its-kind solution that combines direct pricing ...
In the 9 1/2 months since President Trump returned to the White House and FCC leadership transitioned from Jessica Rosenworcel to Brendan Carr, forces behind the transition to ATSC 3.0-powered NEXTGEN ...
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Kinsley Kilpatrick put on a convincing show. During visits to Atlanta VA ...
Thousands of North Korean IT workers have reportedly penetrated the tech sector in the U.S. and other affluent nations, using artificial intelligence to create false work and identities. This ...
The ALDS begins with a clash between the Seattle Mariners and Detroit Tigers, Saturday at 8:38 p.m. ET, at T-Mobile Park. George Kirby (10-8, 4.21 ERA) gets the start for the Mariners, and Troy Melton ...
Game 1 of a best-of-five MLB American League Division Series between the Seattle Mariners and Detroit Tigers gets underway Saturday, Oct. 4. The Mariners are in the postseason for the first time since ...
Head to NBC and Peacock this Saturday for an exciting Big Ten college football doubleheader. The action kicks off at 3:30 PM ET in Indiana when the Boise State Broncos take on the Notre Dame Fighting ...
The Detroit Tigers have advanced to the ALDS in the 2025 MLB playoffs. Dillon Dingler homered in the sixth inning of Game 3 of the AL wild-card series and the Tigers dropped four more runs on the ...
Shohei Ohtani and the Los Angeles Dodgers host Elly De La Cruz and the Cincinnati Reds in Game 1 of the National League Wild Card Series in the 2025 MLB Playoffs. Blake Snell gets the start on the ...
Data support the potential therapeutic efficacy of ROC-101; justify further development via a Phase 2, proof-of-concept trial in patients with PAH or ILD-PH slated to begin Q4 2025 NATICK, Mass., Sept ...